Decoding primary refractoriness to atezolizumab plus bevacizumab in hepatocellular carcinoma: The myeloid frontier. // Journal of Hepatology. – URL: https://www.sciencedirect.com/science/article/pii/S0168827826028473?dgcid=rss_sd_all
Decoding primary refractoriness to atezolizumab plus bevacizumab in hepatocellular carcinoma: The myeloid frontier. Journal of Hepatology. https://www.sciencedirect.com/science/article/pii/S0168827826028473?dgcid=rss_sd_all
“Decoding primary refractoriness to atezolizumab plus bevacizumab in hepatocellular carcinoma: The myeloid frontier.” Journal of Hepatology.
@article{article53574,
title = {Decoding primary refractoriness to atezolizumab plus bevacizumab in hepatocellular carcinoma: The myeloid frontier},
journal = {Journal of Hepatology},
url = {https://www.sciencedirect.com/science/article/pii/S0168827826028473?dgcid=rss_sd_all}
}